Arbutus Biopharma Files 8-K
Ticker: ABUS · Form: 8-K · Filed: Apr 15, 2026
Sentiment: neutral
Topics: 8-K, regulatory-filing, exhibit
TL;DR
Arbutus Biopharma filed an 8-K on 4/15/26. Details to follow.
AI Summary
Arbutus Biopharma Corp. filed an 8-K on April 15, 2026, reporting other events and financial statements/exhibits as of April 14, 2026. The filing includes a press release as an exhibit, but no specific details regarding the nature of the events or financial information are provided in this summary.
Why It Matters
This 8-K filing indicates that Arbutus Biopharma has made a significant regulatory submission or announcement, which could impact its stock price and future business operations.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate disclosed material events, suggesting a routine update.
Key Numbers
- 0001171843-26-002458 — SEC Accession Number (Unique identifier for this specific filing)
- 001-34949 — File Number (SEC file number associated with Arbutus Biopharma Corp.)
Key Players & Entities
- Arbutus Biopharma Corp. (company) — Filer of the 8-K report
- 0001447028 (company) — CIK number for Arbutus Biopharma Corp.
- 2026-04-15 (date) — Filing date of the 8-K
- 2026-04-14 (date) — Period of report for the 8-K
FAQ
What specific 'Other Events' are detailed in the press release filed as Exhibit 99.1?
The provided filing details do not specify the content of the press release, only that it is included as Exhibit 99.1.
What is the nature of the financial statements and exhibits being filed under Item 9.01?
The filing indicates that financial statements and exhibits are being filed, but their specific content is not detailed in the summary information.
What is the significance of the filing date April 15, 2026, and the period of report date April 14, 2026?
The filing date is when the report was officially submitted to the SEC, and the period of report date indicates the cutoff for the information contained within the filing.
What is the business address and contact phone number for Arbutus Biopharma Corp. listed in the filing?
The business address is 701 VETERANS CIRCLE WARMINSTER PA 18974, and the contact phone number is 604-419-3200.
What SIC code is associated with Arbutus Biopharma Corp. in this filing?
The SIC code listed is 2834, which corresponds to Pharmaceutical Preparations, with a CF Office classification of 03 Life Sciences.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2026 regarding Arbutus Biopharma Corp (ABUS).